₹79.5
(Inclusive of all Taxes)
Get Free delivery (₹99) with



Composition :
Manufacturer/Marketer :
Consume Type :
Expires on or after :
Return Policy :
About Hetriva 27 Transdermal Patches 15's
Hetriva 27 Transdermal Patches 15's used to treat dementia (memory loss) associated with Alzheimer's disease (a brain disorder that slowly destroys memory and thinking) and Parkinson's disease (a movement disorder that causes tremors and stiffness).
Hetriva 27 Transdermal Patches 15's contains Rivastigmine, which increases the levels of a brain chemical called acetylcholine by blocking the enzyme responsible for its breakdown. This helps nerve cells communicate more effectively, supporting clearer thinking and improved memory.
Hetriva 27 Transdermal Patches 15's is only for topical use (skin). Apply the patch exactly as prescribed by your doctor. Hetriva 27 Transdermal Patches 15's may cause common side effects, including skin irritation at the application site, nausea, vomiting, dizziness, drowsiness, shakiness (tremor), weakness, weight loss, and loss of appetite. Please consult your doctor if these side effects persist or worsen.
Inform your doctor if you are allergic to Hetriva 27 Transdermal Patches 15's or any of its components. Let your doctor know beforehand if you have breathing problems (asthma or COPD), stomach ulcers or bleeding, seizures, urination problems, or heart, liver, or kidney disease. Consult your doctor before using Hetriva 27 Transdermal Patches 15's if you are pregnant, planning to become pregnant, or breastfeeding. Hetriva 27 Transdermal Patches 15's is not recommended for use in children below 18 years of age.
Uses of Hetriva 27 Transdermal Patches 15's
Hetriva 27 Transdermal Patches 15's is used in the treatment of dementia (memory loss) related to Alzheimer's and Parkinson's disease. The detailed uses of Hetriva 27 Transdermal Patches 15's are as follows:

Have a query?
Directions for Use
Key Benefits
Hetriva 27 Transdermal Patches 15's offers the following medicinal benefits:
How Hetriva 27 Transdermal Patches 15's Works
Storage
What if I have taken an overdose of Hetriva 27 Transdermal Patches 15's
Drug Warnings
Diet & Lifestyle Advise
Dietary recommendations:
Physical activity:
Mental well-being:
Habit Forming
Therapeutic Class
Alcohol
Unsafe
It is advised to avoid alcohol consumption while using Hetriva 27 Transdermal Patches 15's. Alcohol intake, along with Hetriva 27 Transdermal Patches 15's, may cause increased dizziness and drowsiness. Please consult your doctor for more information.
Pregnancy
Caution
Hetriva 27 Transdermal Patches 15's should be used during pregnancy only if the benefit outweighs the risk. Please consult your doctor before using Hetriva 27 Transdermal Patches 15's if you are pregnant or planning to conceive.
Breast Feeding
Caution
It is not known if Hetriva 27 Transdermal Patches 15's is excreted into breast milk. Please consult your doctor before using Hetriva 27 Transdermal Patches 15's if you are breastfeeding.
Driving
Caution
Hetriva 27 Transdermal Patches 15's may cause dizziness or drowsiness. Do not drive if you experience any symptoms that affect your ability to drive or operate machinery.
Liver
Caution
Please consult your doctor before using Hetriva 27 Transdermal Patches 15's if you have liver problems.
Kidney
Caution
Please consult your doctor before using Hetriva 27 Transdermal Patches 15's if you have kidney impairment.
Children
Caution
It is unknown whether Hetriva 27 Transdermal Patches 15's is safe for use in patients under 18 years of age. Please consult a physician for further information.
Heart
Caution
Hetriva 27 Transdermal Patches 15's should be used with caution in patients with cardiovascular disease. Please inform your doctor about any existing heart problems before using Hetriva 27 Transdermal Patches 15's.
Geriatrics
Caution
Hetriva 27 Transdermal Patches 15's should be used with caution in elderly patients. Please consult your doctor before use.
Hetriva 27 Transdermal Patches 15's used to treat dementia (memory loss) associated with Alzheimer's disease (a brain disorder that slowly destroys memory and thinking) and Parkinson's disease (a movement disorder that causes tremors and stiffness).
Hetriva 27 Transdermal Patches 15's contains Rivastigmine, which increases the levels of the brain chemical acetylcholine by blocking the enzyme that breaks it down. This helps nerve cells to communicate more easily, supporting clearer thinking and better memory.
Hetriva 27 Transdermal Patches 15's should be used with caution in the medical history of liver or kidney diseases, breathing problems (asthma and COPD), stomach/intestinal problems (ulcers and bleeding), heart diseases (sick sinus syndrome and other conduction disorders), fainting, fits, urination problems, and enlarged prostate. Please let your doctor know if you have any other medical problems before starting Hetriva 27 Transdermal Patches 15's.
The transdermal patch is to be evenly applied to the skin without hair. It is advised to put the transdermal patch on clean, dry, and healthy skin on the upper or lower back. You can also apply it to the upper arm or chest. The patch should not be applied to damaged or broken skin. Please do not apply a new patch if you are already using one, as it can lead to overdosing. Do not apply creams, oils, lotions, or powders to the application site. Sometimes, a patch may contain metal. Therefore, it is recommended to remove the patch before undergoing MRI.
After using the patch, fold it in half with the adhesive surfaces pressed together inwards, and discard it safely.
Country of origin
Manufacturer/Marketer address
We provide you with authentic, trustworthy and relevant information